Structure-release rate correlation in collagen gels containing fluorescent drug analog

被引:25
作者
Lacerda, SHD
Ingber, B
Rosenzweig, N [1 ]
机构
[1] Univ New Orleans, AMRI, New Orleans, LA 70148 USA
[2] USDA, New Orleans, LA 70179 USA
关键词
collagen; EDAC; cross linking; drug delivery; chondroitin-6-sulfate; collagenase;
D O I
10.1016/j.biomaterials.2005.05.032
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The paper examines the release properties of collagen gels that contain covalently bound fluorescent drug analogs. Collagen gels were prepared by fibrilogenesis. The gels were stabilized by cross linking with EDAC/NHS. SEM studies showed that increasing the cross-linking time with EDAC/NHS resulted in decreasing pore size and increasing gel density. Fluorescence spectroscopy measurements showed a clear correlation between decreasing pore size and increasing gel density, and lower release rate from the gels. Additives like chondrotitin-6-sulfate (CS) and amino acids altered the release properties of the cross-linked collagen gels. CS increased the stability of collagen gels to enzymatic degradation and non-enzymatic degradation. This was attributed to increasing gel rigidity due to carbohydrate-protein interactions. The amino acid lysine increased the stability of collagen gels which was attributed to increasing cross-linking level between the collagen fibrils and the primary amine group on the lysine side chain. The amino acid histidine decreased the stability of the gels, particularly to non-enzymatic degradation. These results correlated with increasing pore size following treatment with histidine. Our study shows, for the first time, a clear correlation between structure and release properties of collagen gels. It describes in detail the effect of additives on the structural and release properties of collagen gels. The study focused on gels that were prepared through fibrillogenesis and were therefore similar in structure to native collagen. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7164 / 7172
页数:9
相关论文
共 31 条
[11]  
JUIJPERS AJ, 2000, MACROMOLECULES, V33, P3705
[12]   Collagenous matrices as release carriers of exogenous growth factors [J].
Kanematsu, A ;
Yamamoto, S ;
Ozeki, M ;
Noguchi, T ;
Kanatani, I ;
Ogawa, O ;
Tabata, Y .
BIOMATERIALS, 2004, 25 (18) :4513-4520
[13]   Biomedical applications of collagen [J].
Lee, CH ;
Singla, A ;
Lee, Y .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 221 (1-2) :1-22
[14]   An infection-preventing bilayered collagen membrane containing antibiotic-loaded hyaluronan microparticles: Physical and biological properties [J].
Lee, JE ;
Park, JC ;
Lee, KH ;
Oh, SH ;
Kim, JG ;
Suh, H .
ARTIFICIAL ORGANS, 2002, 26 (07) :636-646
[15]   Enhanced biological stability of collagen porous scaffolds by using amino acids as novel cross-linking bridges [J].
Ma, L ;
Gao, CY ;
Mao, ZW ;
Zhou, J ;
Shen, JC .
BIOMATERIALS, 2004, 25 (15) :2997-3004
[16]  
Ma L, 2003, J BIOMAT SCI-POLYM E, V14, P861
[17]   Denatured thiolated collagen .2. Cross-linking by oxidation [J].
Nicolas, FL ;
Gagnieu, CH .
BIOMATERIALS, 1997, 18 (11) :815-821
[18]   Recombinant collagen and gelatin for drug delivery [J].
Olsen, D ;
Yang, CL ;
Bodo, M ;
Chang, R ;
Leigh, S ;
Baez, J ;
Carmichael, D ;
Perälä, M ;
Hämäläinen, ER ;
Jarvinen, M ;
Polarek, J .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (12) :1547-1567
[19]   Investigation into the biological stability of collagen/chondroitin-6-sulphate gels and their contraction by fibroblasts and keratinocytes: the effect of crosslinking agents and diamines [J].
Osborne, CS ;
Reid, WH ;
Grant, MH .
BIOMATERIALS, 1999, 20 (03) :283-290
[20]   Degradation of a collagen-chondroltin-6-sulfate matrix by collagenase and by chondroitinase [J].
Pek, YS ;
Spector, M ;
Yannas, IV ;
Gibson, LJ .
BIOMATERIALS, 2004, 25 (03) :473-482